← Leaderboards
David Matthew Kern
University Of California Berkeley
$133,052
Attributed
$133,052
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $69.3K · FY2019–20$100K$75K$50K$25K$0
'19
'20
Funding mix
By agency
NIH$133,052 · 1
By mechanism
F32$133,052 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Berkeley
Same institution · by research overlap
- John F Hartwig$20,033,439
- Rebecca W Heald$19,460,269
- Joseph Aurelio Bonanno$11,050,029
- James H Hurley$19,711,339
- Jamie H Cate$19,005,233
Others in their field
Other Emerging Leaders on “Antineoplastic Agents”
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$29,626,259
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Jeffrey H. Price · Vala Sciences, Inc.$5,562,326
Research focus
Antineoplastic AgentsArchitectureBehaviorBiochemicalCell GrowthCellsCell SizeCell TypeCellular TargetingCell VolumesCessation Of LifeChloride IonCisplatinComplexCoupledCryoelectron MicroscopyCrystallographyCytolysisDetergentsElectrophysiology (Science)EnvironmentExperimental StudyExposure ToAnions